Details for New Drug Application (NDA): 077897
✉ Email this page to a colleague
The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Summary for 077897
Tradename: | ADENOSINE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | adenosine |
Patents: | 0 |
Pharmacology for NDA: 077897
Mechanism of Action | Adenosine Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 077897
Suppliers and Packaging for NDA: 077897
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077897 | ANDA | Fresenius Kabi USA, LLC | 63323-651 | 63323-651-20 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-651-20) / 20 mL in 1 VIAL, SINGLE-DOSE |
ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 077897 | ANDA | Fresenius Kabi USA, LLC | 63323-651 | 63323-651-30 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-651-30) / 30 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 60MG/20ML (3MG/ML) | ||||
Approval Date: | Nov 27, 2017 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 90MG/30ML (3MG/ML) | ||||
Approval Date: | Nov 27, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription